Biostatistician Margaret Gamalo says innovation in statistics and regulatory science involves incremental progress, requires the engagement of various stakeholders, and often unfolds in a nonlinear manner.
cder
Registration Open for Symposium on AI in Pharmaceutical Medicine
The symposium, which can be attended in person or virtually, will take place June 10–11 at the Northeastern University campus in Boston with the theme Generative AI in Medical Research and Drug Development: Hype or Reality?
Meet Sylva Collins, Director of the Office of Biostatistics, US Food and Drug Administration
Sylva Collins joined the FDA’s Office of Biostatistics in 2019 and has more than 30 years of drug development experience and biostatistics leadership.